title: Altered temporal patterns of anxiety in aged and amyloid precursor protein (APP) transgenic mice.
abstract: Both normal aging and dementia are associated with dysregulation of the biological clock, which contributes to disrupted circadian organization of physiology and behavior. Diminished circadian organization in conjunction with the loss of cholinergic input to the cortex likely contributes to impaired cognition and behavior. One especially notable and relatively common circadian disturbance among the aged is "sundowning syndrome," which is characterized by exacerbated anxiety, agitation, locomotor activity, and delirium during the hours before bedtime. Sundowning has been reported in both dementia patients and cognitively intact elderly individuals living in institutions; however, little is known about temporal patterns in anxiety and agitation, and the neurobiological basis of these rhythms remains unspecified. In the present study, we explored the diurnal pattern of anxiety-like behavior in aged and amyloid precursor protein (APP) transgenic mice. We then attempted to treat the observed behavioral disturbances in the aged mice using chronic nightly melatonin treatment. Finally, we tested the hypothesis that time-of-day differences in acetylcholinesterase and choline acetyltransferase expression and general neuronal activation (i.e., c-Fos expression) coincide with the behavioral symptoms. Our results show a temporal pattern of anxiety-like behavior that emerges in elderly mice. This behavioral pattern coincides with elevated locomotor activity relative to adult mice near the end of the dark phase, and with time-dependent changes in basal forebrain acetylcholinesterase expression. Transgenic APP mice show a similar behavioral phenomenon that is not observed among age-matched wild-type mice. These results may have useful applications to the study and treatment of age- and dementia-related circadian behavioral disturbances, namely, sundowning syndrome.
authors.affiliation: Department of Neuroscience, Institute for Behavioral Medicine Research, Ohio State University Medical Center, Columbus, OH 43210, USA. tracy.bedrosian@osumc.edu
authors.forename: Tracy A
authors.initials: TA
authors.lastname: Bedrosian
authors.forename: Kamillya L
authors.initials: KL
authors.lastname: Herring
authors.forename: Zachary M
authors.initials: ZM
authors.lastname: Weil
authors.forename: Randy J
authors.initials: RJ
authors.lastname: Nelson
mesh_terms: D000375:Aging / Q000097:blood / Q000502:physiology* / Q000523:psychology*; D000544:Alzheimer Disease / Q000503:physiopathology / Q000523:psychology; D016564:Amyloid beta-Protein Precursor / Q000235:genetics / Q000502:physiology*; D000818:Animals; D001007:Anxiety / Q000097:blood / Q000503:physiopathology* / Q000523:psychology*; D020532:Basal Nucleus of Meynert / Q000378:metabolism; D001522:Behavior, Animal / Q000187:drug effects / Q000502:physiology; D002795:Choline O-Acetyltransferase / Q000378:metabolism; D021081:Chronobiology Disorders / Q000503:physiopathology* / Q000523:psychology*; D002940:Circadian Rhythm / Q000187:drug effects / Q000502:physiology; D003345:Corticosterone / Q000097:blood; D003704:Dementia / Q000503:physiopathology / Q000523:psychology; D004195:Disease Models, Animal; D006801:Humans; D008297:Male; D008550:Melatonin / Q000494:pharmacology; D051379:Mice; D008810:Mice, Inbred C57BL; D008822:Mice, Transgenic; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism
chemical_list: D016564:Amyloid beta-Protein Precursor; D016760:Proto-Oncogene Proteins c-fos; D002795:Choline O-Acetyltransferase; D008550:Melatonin; D003345:Corticosterone